Seoul [South Korea]: Seegene, a Korean molecular diagnostic company, announced on the 29th that it will export 1.7 million doses of COVID-19 test reagent to Israel.
As urgent demand for test reagent increased due to COVID-19 Omicron variant, Seegene has decided to ship products by a chartered flight. The flight will depart from Incheon Airport on the 29th, and will arrive in Israel on the 30th.
Seegene said that the diagnostic reagent exported to Israel can detect Omicron variants as well as existing COVID-19 viruses.
This product can detect four existing COVID-19 virus genes and five variant genes. It diagnoses Omicron variant by detecting three variant genes included in Omicron virus. (ANI/Global Economic)
Must Read
- Israel to donate one million COVID-19 vaccine doses to…
- India and Israel victims of terror, have to make terrorism…
- UNICEF To Supply 220 Million Doses Of The Johnson & Johnson…
- India and Israel agree on mutual recognition of COVID…
- Israel reports 2,967 daily COVID-19 cases, highest since…
- Philippines' COVID-19 cases tops 2 million as Delta virus…
- Africa's COVID-19 cases exceed 9.25 million
- Record 1.7 million people in UK tested positive for COVID-19…
- Africa's COVID-19 cases surpass 9.33 million
- Over 1 million new COVID-19 cases reported in US